David D. Davidar, Director at GLOBUS MEDICAL INC (GMED), sold 40,000 shares at $85.00 ($3.4M) on 2024-11-22, disclosed to the SEC on 2024-11-25.
Scheduled sale ($3.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.00 | 13,234 | $1.1M | 33.1% |
| 2 | $85.00 | 13,254 | $1.1M | 33.1% |
| 3 | $85.00 | 6,746 | $573K | 16.9% |
| 4 | $85.00 | 6,766 | $575K | 16.9% |
| Total | $85.00 avg | 40,000 | $3.4M | 100% |
| Filing → |
| GMED | SELL | 2024-10-18 | $3.8M | — | Filing → |
| GMED | SELL | 2024-09-17 | $3.5M | — | Filing → |
| GMED | SELL | 2024-05-10 | $1.3M | — | Filing → |